Tuesday 13 October 2026
Export SLSN’s income statement to Excel — free account
Solesence, Inc.
SLSN Consumer Defensive Household & Personal Products
Solesence, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $62.1 million, up 18.6% from fiscal 2024. In the quarter to June 2026, revenue fell 24.7%, EPS fell 105.5%, free cash flow grew 86.5% and total debt rose 36.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.02
0.00
0.00%
Follow SLSN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 115.85 | 82.90 | 211.84 |
+8 more quarters Free account |
P/S ratio |
0.94 | 1.11 | 1.81 | 3.65 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
273.67 | 44.23 | 61.87 | (90.41) | |
P/B ratio |
3.97 | 3.95 | 7.99 | 13.18 | |
Price to Tangible BV |
3.97 | 3.95 | 7.99 | 13.18 | |
EV/Sales |
1.37 | 1.33 | 2.04 | 3.83 | |
EV/EBITDA |
0.00 | 44.58 | 51.25 | 90.49 | |
EV/Operating CF |
74.82 | 468.23 | (14.77) | (29.05) | |
EV/FCF |
(89.53) | (30.41) | (11.81) | (19.07) | |
Quick Ratio |
0.40 | 0.55 | 0.58 | 0.57 | |
Current Ratio |
0.97 | 2.08 | 1.81 | 1.84 | |
Net Debt/EBITDA |
29.82 | (67.93) | (88.47) | (18.11) | |
Debt/Assets |
30.77% | 28.34% | 32.83% | 19.45% | |
Debt/Equity |
1.09 | 0.80 | 1.08 | 0.61 | |
Asset Turnover |
1.04 | 1.15 | 1.29 | 1.22 | |
Operating CF/Net income |
(1.21) | (1.98) | (4.51) | 2.24 | |
Capex/Depreciation |
(1.45) | (1.69) | (2.04) | (1.86) | |
Interest Coverage |
0.43 | (1.92) | (1.15) | (2.30) | |
Research and Development Expense of Revenue |
6.18% | 8.04% | 8.29% | 7.41% | |
Selling, General and Administrative Expense of Revenue |
24.00% | 21.60% | 17.72% | 21.02% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.52% | 0.64% | 1.65% | 0.84% | |
Graham Net Nets |
(0.15) | (0.07) | (0.06) | (0.02) | |
Graham Number |
0.00 | 0.21 | 0.29 | 0.29 | |
Earnings Yield |
(4.59%) | 0.86% | 1.21% | 0.47% | |
Free Cash Flow Yield |
(1.62%) | (3.92%) | (9.52%) | (5.50%) | |
Revenue per Share |
0.22 | 0.18 | 0.18 | 0.21 | |
Operating CF per Share |
0.00 | 0.02 | 0.03 | (0.04) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Free Cash Flow per Share |
0.00 | 0.01 | 0.02 | (0.04) | |
Cash per Share |
0.01 | 0.01 | 0.02 | 0.01 | |
Shareholders Equity per Share |
0.19 | 0.24 | 0.20 | 0.24 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.19 | 0.24 | 0.20 | 0.24 | |
Free Cash Flow |
(0.28) | 0.99 | 1.37 | (2.93) | |
Working Capital |
(0.74) | 13.72 | 11.30 | 14.93 | |
Capital Expenditures |
(0.47) | (0.53) | (0.45) | (0.42) | |
Net Current Asset Value |
(8.01) | (4.41) | (7.19) | (3.97) | |
EV/EBIT |
0.00 | 98.61 | 80.49 | 137.86 | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.03 | |
Price to Operating Income |
0.00 | 82.63 | 71.60 | 131.45 | |
| Other line items | |||||
Average Receivables |
10.20 | 7.73 | 5.85 | 9.22 | |
Average Payables |
5.93 | 6.92 | 6.60 | 5.69 | |
Average Inventory |
16.39 | 19.74 | 17.62 | 16.96 | |
Average Assets |
53.20 | 52.41 | 48.25 | 51.02 | |
Average Common Equity |
15.67 | 16.06 | 14.52 | 16.20 |
Columns are period end dates